Cargando…
Influence of Metabolic, Transporter, and Pathogenic Genes on Pharmacogenetics and DNA Methylation in Neurological Disorders
SIMPLE SUMMARY: The prevalence of neurodegenerative disorders has increased, yet reliable, pre-symptomatic biomarkers for early detection and subsequent preventive interventions remain elusive. The aim of our study was to understand the interplay between DNA methylation, a crucial biological process...
Autores principales: | Martínez-Iglesias, Olaia, Naidoo, Vinogran, Carrera, Iván, Carril, Juan Carlos, Cacabelos, Natalia, Cacabelos, Ramón |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10525670/ https://www.ncbi.nlm.nih.gov/pubmed/37759556 http://dx.doi.org/10.3390/biology12091156 |
Ejemplares similares
-
Influence of Pathogenic and Metabolic Genes on the Pharmacogenetics of Mood Disorders in Alzheimer’s Disease
por: Cacabelos, Ramón, et al.
Publicado: (2021) -
Nosustrophine: An Epinutraceutical Bioproduct with Effects on DNA Methylation, Histone Acetylation and Sirtuin Expression in Alzheimer’s Disease
por: Martínez-Iglesias, Olaia, et al.
Publicado: (2022) -
DNA Methylation in Neurodegenerative and Cerebrovascular Disorders
por: Martínez-Iglesias, Olaia, et al.
Publicado: (2020) -
Gene Expression Profiling as a Novel Diagnostic Tool for Neurodegenerative Disorders
por: Martínez-Iglesias, Olaia, et al.
Publicado: (2023) -
Epigenetic Biomarkers as Diagnostic Tools for Neurodegenerative Disorders
por: Martínez-Iglesias, Olaia, et al.
Publicado: (2021)